At present, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has quickly become a health emergency because no specifics vaccines or drugs, at this moment, are available. Recent studies have shown that the transplantation of mesenchymal stem cells (MSCs) into Coronavirus Disease 2019 (COVID-19) patients could represent a promising strategy for the development of new therapeutic methods. We speculate and suggest that the secretome of human Oral Tissue Stem Cells (hOTSCs), for their immunomodulatory and anti-inflammatory specific properties, could exert beneficial effects on the COVID-19 patients through an innovative aerosolisation technique. This non-invasive technique can offer multiple advantages in prophylaxis, as well as the prevention and treatment of severe epidemic respiratory syndrome with minimum risk and optimal therapeutic effects. This has the potential to create a novel pathway towards immunomodulatory therapy for the treatment of COVID-19 positive patients.
【저자키워드】 COVID-19, coronavirus, immunomodulation, Mesenchymal stem cells, human Oral Tissue Stem Cells, 【초록키워드】 Treatment, SARS-CoV-2, Vaccine, Anti-inflammatory, Infection, drugs, risk, MSCs, Prophylaxis, Epidemic, immunomodulatory, therapeutic, Patient, pathway, oral, immunomodulatory therapy, Coronavirus-2, COVID-19 patient, stem cell, Secretome, health emergency, Non-invasive, acute respiratory syndrome, syndrome, therapeutic effects, COVID-19 positive patients, offer, Effect, recent, STEM, shown, 【제목키워드】 oral, STEM,